Cross-National Evidence On Generic Pharmaceuticals: Pharmacy Vs. Physician-Driven Markets

This paper examines the role of regulation and competition in generic markets. Generics offer large potential savings to payers and consumers of pharmaceuticals. Whether the potential savings are realized depends on the extent of generic entry and uptake and the level of generic prices. In the U.S., the regulatory, legal and incentive structures encourage prompt entry, aggressive price competition and patient switching to generics. Key features are that pharmacists are authorized and incentivized to switch patients to cheap generics. By contrast, in many other high and middle income countries, generics traditionally competed on brand rather than price because physicians rather than pharmacies are the decision-makers.

Provided by: National Bureau of Economic Research Topic: Software Date Added: Jul 2011 Format: PDF

Find By Topic